22 results
8-K
EX-99.1
SABS
SAB Biotherapeutics Inc
29 Mar 24
SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results
9:35am
also been deeply involved in the type 1 diabetes community for over 20 years, including as a volunteer and member of the Young
Leadership Committee
8-K
EX-99.1
SABS
SAB Biotherapeutics Inc
29 Nov 23
SAB Biotherapeutics Announces Commencement of the HUMAN Phase 1 Clinical Trial with SAB-142, a Potential Disease-Modifying
7:40am
.
“For people living with T1D, the burden of disease is significant and there’s increasing focus – and need – within the research community to focus
8-K
SABS
SAB Biotherapeutics Inc
2 Oct 23
SAB Biotherapeutics Announces Private Placement of up to $130 Million to Advance Development of Lead Drug Candidate for Type 1 Diabetes
4:10pm
Chapter of the JDRF and was Chair of the Board of Trustees at the Great Neck Community School. Andrew received a B.A. in Economics, with distinction, from
424B3
gb2a2fn7
29 Apr 22
Prospectus supplement
4:16pm
POS AM
mlsxnsf
20 Apr 22
Prospectus update (post-effective amendment)
4:56pm
424B3
2wx iq590
29 Dec 21
Prospectus supplement
4:01pm
424B3
dhgvgfz
24 Sep 21
Prospectus supplement
5:01pm
424B3
oshnh3i0
23 Sep 21
Prospectus supplement
4:36pm
S-4/A
q14hd10gloa 6prqw3c
8 Sep 21
Registration of securities issued in business combination transactions (amended)
2:59pm
425
fc8l6m55 k8m7dfl
7 Sep 21
Business combination disclosure
10:36am
S-4
99enrh22wvwvysf8t4
17 Aug 21
Registration of securities issued in business combination transactions
6:08am
8-K
EX-2.1
84jmffr6qi
22 Jun 21
Entry into a Material Definitive Agreement
9:05am
425
EX-2.1
f9xuy880dgozuovev
22 Jun 21
Business combination disclosure
9:03am
424B4
cx1trf 2n9
12 Jan 21
Prospectus supplement with pricing info
4:05pm